What is STERIS plc (STE)?

STERIS plc (STE) is a stock in the Healthcare sector, Medical - Specialties industry. View full analysis on Stocks360.

What is the current price of STE?

The current price of STE is $232.14. Prices are updated in real time on Stocks360.

What is STE's price-to-earnings (PE) ratio?

STE's trailing twelve-month PE ratio is 28.31, based on current price and earnings per share data available on Stocks360.

What is STE's market capitalization?

STE's market capitalization is $22,633,673,214.00, placing it in the large-cap tier.

Does STE pay a dividend?

Yes. STE has a trailing twelve-month dividend yield of 0.01%. Dividend data is sourced from financial market providers and displayed on Stocks360.

STERIS plc (STE)

Stock analysis · NYSE · Healthcare · Medical - Specialties

$232.14

Market Cap

$22.63B

PE (TTM)

28.31

EPS (TTM)

N/A

Dividend Yield

1.11%

Beta

0.93

Day Range

$229.21 – $232.41

52-wk Range

$195.14 – $269.44

Avg Volume

N/A

Volume

485.76K

STERIS plc (STE) is a publicly traded company in the Healthcare sector. Latest price: $232.14. Market cap $22.63B. Trailing PE 28.31. Dividend yield 1.11%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 4 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-30 · $236.19 2026-10-29 · $232.14 (-1.71%)

Earnings

Most Recent

Aug 5, 2026

EPS $2.59 vs est. $2.49

Beat by $0.10

Next Earnings

Nov 4, 2026

EPS estimate $2.67

Proprietary Signals

Signal snapshot temporarily unavailable.

About STERIS plc

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. It offers a range of products including cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, lights, and connectivity solutions. It also provides services such as equipment maintenance, instrument repair, and contract sterilization for medical device and pharmaceutical manufacturers.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	28.31×
P/S (TTM)	3.75×
P/B	3.14×
PEG	1.13×
P/FCF (TTM)	24.45×
EV / EBITDA	14.84×
EV / Sales	4.01×
Earnings Yield	3.55%
Free Cash Flow Yield	4.09%
Dividend Yield	1.11%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$24.20B
Revenue (TTM)	$6.04B
Net Income (TTM)	$804.28M
Free Cash Flow (TTM)	$970.57M
Net Debt	$1.56B
Working Capital	$1.16B
Gross Margin	44.43%
Operating Margin	18.91%
Net Margin	13.33%
Return on Equity	11.27%
Return on Invested Capital	8.71%